Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Invictus MD Strategies Corp IVITF

Invictus MD Strategies Corp is a cannabis company with a focus on the Canadian cannabis space, offering a selection of products under a wide range of cannabinoid profiles that fit the demand of the company's medical clients and retail customers. Its wholly-owned subsidiary's Phase I and Phase II facilities are in full production. The company's 50% owned subsidiary has completed its Phase II... see more

GREY:IVITF - Post Discussion

Invictus MD Strategies Corp > Floating shares.
View:
Post by Tigerwoods3672 on Feb 21, 2019 12:34pm

Floating shares.

Anyone know what the floating shares will be when the Nasdaq is approved and the reverse split happens? Just trying to compare it to Tilray and Canntrust. (Not that this is a comparable company)
Comment by timetoscorebig on Feb 21, 2019 12:36pm
This post has been removed in accordance with Community Policy
Comment by blueangelbird on Feb 21, 2019 1:13pm
5 - 1 reverde split
Comment by run33 on Feb 21, 2019 1:58pm
It will be 24.04M.... (120M  / 5:1 rollback). $5.00 CAD share price (Assuming $1.00 rolled back 5:1) is $3.78 $US. What's hilarious.... is Tilray's book value (pre IPO funding) is less than Invictus is right now, and they received a $1.4B valuation. (PRE-IPO funding!) $106MM US book  for Tilray vs. $144MM CAD book for GENE. GENE also has $24MM CAD liabilities vs. Tilrays ...more  
Comment by Tigerwoods3672 on Feb 21, 2019 3:13pm
Thanks! Exactly what I was looking for.
Comment by Medinecheck on Feb 22, 2019 4:55am
Excellent Reserach by run33 ! I hope these facts will be discovered soon by some institutional investors.
Comment by MoneyTalks7 on Feb 22, 2019 10:02am
Thanks for sharing run, your research says it all in a nutshell.
Comment by Stopthenoise on Feb 21, 2019 2:01pm
5-1 reverse split. they talked about a 7-1 but the official release was 5-1
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities